Cargando…
Protocadherin 20 maintains intestinal barrier function to protect against Crohn’s disease by targeting ATF6
BACKGROUND: Intestinal barrier dysfunction plays a central role in the pathological onset of Crohn’s disease. We identify the cadherin superfamily member protocadherin 20 (PCDH20) as a crucial factor in Crohn’s disease. Here we describe the function of PCDH20 and its mechanisms in gut homeostasis, b...
Autores principales: | Huang, Shanshan, Xie, Zhuo, Han, Jing, Wang, Huiling, Yang, Guang, Li, Manying, Zhou, Gaoshi, Wang, Ying, Li, Lixuan, Li, Li, Zeng, Zhirong, Yu, Jun, Chen, Minhu, Zhang, Shenghong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320870/ https://www.ncbi.nlm.nih.gov/pubmed/37407995 http://dx.doi.org/10.1186/s13059-023-02991-0 |
Ejemplares similares
-
Hypermethylation of miR-145 promoter-mediated SOX9-CLDN8 pathway regulates intestinal mucosal barrier in Crohn's disease
por: Zhuang, Xiaojun, et al.
Publicado: (2022) -
A Novel Model Based on Serum Biomarkers to Predict Primary Non-Response to Infliximab in Crohn’s Disease
por: Li, Li, et al.
Publicado: (2021) -
Serum exosomal microRNA-144-3p: a promising biomarker for monitoring Crohn's disease
por: Chen, Peng, et al.
Publicado: (2021) -
Thalidomide Combined With Azathioprine as Induction and Maintenance Therapy for Azathioprine-Refractory Crohn's Disease Patients
por: Li, Tong, et al.
Publicado: (2020) -
Decreased expression of protocadherin 20 is associated with poor prognosis in hepatocellular carcinoma
por: Wu, Yanqin, et al.
Publicado: (2016)